Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer

Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T15:42:42.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice informs visitors that NIH websites are transitioning and may use “Super Intelligence” alongside “Artificial Intelligence” during the change.
    Difference
    0.8%
    Check dated 2026-10-25T14:28:08.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:59:13.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site revision label updates from v3.7.0 to v3.7.1, and the right-side utility toolbar is reduced.
    Difference
    0.1%
    Check dated 2026-10-11T14:20:05.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the record history. The older revision v3.6.6 is removed from the history list.
    Difference
    0.1%
    Check dated 2026-09-20T20:54:05.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The record history shows a new site revision (v3.6.6) added and the previous revision (v3.6.5) removed, indicating a recent update to the history-tracking UI.
    Difference
    0.1%
    Check dated 2026-08-30T21:37:11.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.